Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Myong-Jin Kim, PharmD
Division Director
US Food & Drug Administration
Poster(s):
020: A Science-based Approach for Recommendation of Antagonist Blockade in the Bioequivalence Studies of Opioid Drug Products
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT
080: Improving Administration Method Consistency of Product-Specific Guidances for Chewable Tablets & Tablet Products With Chewing in Labeling
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT
082: Swallowability of Solid Oral Drug Products in Regulatory Submissions: Patient-Specific Features, Product Physical Attributes & Clinical Swallowability Study Designs
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT
